Adults with severe sickle cell disease were successfully treated with a stem cell transplant approach that doesn't require extensive immune-suppressing drugs. Further follow-up and testing will be needed to assess the potential new therapy. Blood drawn from a sickle cell patient (top) and a patient after stem-cell transplant (bottom). The limitation in allogeneic stem cell treatment is that this process carries the risk of developing GVHD, whereby the patient’s body rejects the donor stem cells. While in an autologous stem cell transplant the patient receives stem cells from his own blood. This type of stem cell treatment is mostly used in the treatment of solid tumors.
Dec 16, · Results from the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) prospective, multi-center, blinded, RCT were reported by Bartunek and colleagues (). The primary endpoint of the study was feasibility and safety of autologous BM-derived cardiopoietic stem cell therapy at 2 . One viable treatment option for multiple myeloma patients is a stem cell transplant. Learn about the procedure, costs, risks, and recovery of a bone marrow transplant.
Autologous stem-cell transplantation (also called autogenous, autogeneic, or autogenic stem-cell transplantation and abbreviated auto-SCT) is autologous transplantation of stem cells —that is, transplantation in which stem cells (undifferentiated cells from which other cell types develop) are removed from a person, stored, and later given back to that same person. Oct 17, · [bctt tweet="Largest safety trial of #StemCells from fat underscores the safety of autologous stem cell therapy latins.xyz - @USStemCellInc"] During the study, approximately 60 mL of fat tissue was removed from the abdomen or flanks of each participating patient using a local tumescent liposuction procedure.